Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin Campbell

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
European Journal of Psychotraumatology|August 16, 2024
Defining military sexual trauma: establishing parameters and perspectivesCharlotte Herriott, Gavin Campbell, Lauren Godier-McBard, et al.
European Journal of Psychotraumatology|October 21, 2025
Moral injury prevention and interventionVictoria Williamson, Radha Kothari, Amanda Bonson, et al.
BMC Medical Ethics|February 21, 2023
Improving oncology first-in-human and Window of opportunity informed consent forms through participant feedbackAnna M Avinger, Hannah Claire Sibold, Gavin Campbell, et al.
Ethics & Human Research|February 26, 2022
Therapeutic Misconception about Research Procedures: Does a Simple Information Chart Improve Understanding?Gavin Campbell, Margie D Dixon, Minisha Lohani, et al.
Leukemia|February 27, 2024
Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemiaRuth de Tute, Nicholas Counsell, Laura Clifton-Hadley, et al.
Blood|April 2, 2008
Novel exon 12 mutations in the HIF2A gene associated with erythrocytosisMelanie J Percy, Philip A Beer, Gavin Campbell, et al.
British Journal of Haematology|May 26, 2020
Real-world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML studyDragana Milojkovic, Nicholas C P Cross, Sahra Ali, et al.
The Lancet. Oncology|November 1, 2019
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trialMark T Drayson, Stella Bowcock, Tim Planche, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
European Journal of Psychotraumatology|August 16, 2024
Defining military sexual trauma: establishing parameters and perspectivesCharlotte Herriott, Gavin Campbell, Lauren Godier-McBard, et al.
European Journal of Psychotraumatology|October 21, 2025
Moral injury prevention and interventionVictoria Williamson, Radha Kothari, Amanda Bonson, et al.
BMC Medical Ethics|February 21, 2023
Improving oncology first-in-human and Window of opportunity informed consent forms through participant feedbackAnna M Avinger, Hannah Claire Sibold, Gavin Campbell, et al.
Ethics & Human Research|February 26, 2022
Therapeutic Misconception about Research Procedures: Does a Simple Information Chart Improve Understanding?Gavin Campbell, Margie D Dixon, Minisha Lohani, et al.
Leukemia|February 27, 2024
Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemiaRuth de Tute, Nicholas Counsell, Laura Clifton-Hadley, et al.
Blood|April 2, 2008
Novel exon 12 mutations in the HIF2A gene associated with erythrocytosisMelanie J Percy, Philip A Beer, Gavin Campbell, et al.
British Journal of Haematology|May 26, 2020
Real-world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML studyDragana Milojkovic, Nicholas C P Cross, Sahra Ali, et al.
The Lancet. Oncology|November 1, 2019
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trialMark T Drayson, Stella Bowcock, Tim Planche, et al.
Pageof 1